Doctors hail new treatment for asthma attacks as ‘game-changer’

Benralizumab - administered by injection - is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a “game-changer” and is the first leap in treatment for 50 years, researchers say. More